vs

Side-by-side financial comparison of Metagenomi, Inc. (MGX) and SOCKET MOBILE, INC. (SCKT). Click either name above to swap in a different company.

SOCKET MOBILE, INC. is the larger business by last-quarter revenue ($4.0M vs $3.9M, roughly 1.0× Metagenomi, Inc.). SOCKET MOBILE, INC. runs the higher net margin — -287.5% vs -576.0%, a 288.6% gap on every dollar of revenue. On growth, SOCKET MOBILE, INC. posted the faster year-over-year revenue change (-17.9% vs -59.3%). SOCKET MOBILE, INC. produced more free cash flow last quarter ($189.3K vs $-23.6M). Over the past eight quarters, SOCKET MOBILE, INC.'s revenue compounded faster (-10.8% CAGR vs -40.8%).

Metagenomi, Inc. is a clinical-stage biotechnology company focused on developing metagenomics-powered gene editing therapeutics. It leverages massive microbial genome datasets to identify novel, precise CRISPR and alternative gene editing tools, advancing pipelines of in vivo and ex vivo therapies for both rare and common genetic diseases for global biopharma markets.

Socket Mobile, Inc. designs, manufactures and sells portable data capture and payment acceptance solutions, including handheld barcode scanners, RFID readers and contactless payment terminals. Its core customer segments cover retail, healthcare, field services and logistics, with products compatible with major mobile operating systems and widely deployed across North America, Europe and Asia Pacific.

MGX vs SCKT — Head-to-Head

Bigger by revenue
SCKT
SCKT
1.0× larger
SCKT
$4.0M
$3.9M
MGX
Growing faster (revenue YoY)
SCKT
SCKT
+41.4% gap
SCKT
-17.9%
-59.3%
MGX
Higher net margin
SCKT
SCKT
288.6% more per $
SCKT
-287.5%
-576.0%
MGX
More free cash flow
SCKT
SCKT
$23.8M more FCF
SCKT
$189.3K
$-23.6M
MGX
Faster 2-yr revenue CAGR
SCKT
SCKT
Annualised
SCKT
-10.8%
-40.8%
MGX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MGX
MGX
SCKT
SCKT
Revenue
$3.9M
$4.0M
Net Profit
$-22.5M
$-11.4M
Gross Margin
50.2%
Operating Margin
-623.0%
-14.9%
Net Margin
-576.0%
-287.5%
Revenue YoY
-59.3%
-17.9%
Net Profit YoY
3.7%
-29977.8%
EPS (diluted)
$-0.59
$-1.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MGX
MGX
SCKT
SCKT
Q4 25
$3.9M
$4.0M
Q3 25
$8.7M
$3.1M
Q2 25
$8.5M
$4.0M
Q1 25
$4.1M
$4.0M
Q4 24
$9.6M
$4.8M
Q3 24
$11.5M
$3.9M
Q2 24
$20.0M
$5.1M
Q1 24
$11.2M
$5.0M
Net Profit
MGX
MGX
SCKT
SCKT
Q4 25
$-22.5M
$-11.4M
Q3 25
$-20.4M
$-1.2M
Q2 25
$-19.9M
$-792.1K
Q1 25
$-25.0M
$-994.1K
Q4 24
$-23.4M
$38.1K
Q3 24
$-18.8M
$-1.1M
Q2 24
$-10.7M
$-607.6K
Q1 24
$-25.1M
$-557.4K
Gross Margin
MGX
MGX
SCKT
SCKT
Q4 25
50.2%
Q3 25
47.7%
Q2 25
49.9%
Q1 25
50.4%
Q4 24
51.0%
Q3 24
49.0%
Q2 24
50.9%
Q1 24
50.3%
Operating Margin
MGX
MGX
SCKT
SCKT
Q4 25
-623.0%
-14.9%
Q3 25
-263.8%
-34.1%
Q2 25
-246.5%
-16.8%
Q1 25
-674.1%
-22.5%
Q4 24
-214.5%
-8.5%
Q3 24
-194.4%
-26.6%
Q2 24
-84.3%
-10.5%
Q1 24
-260.2%
-9.7%
Net Margin
MGX
MGX
SCKT
SCKT
Q4 25
-576.0%
-287.5%
Q3 25
-235.5%
-38.6%
Q2 25
-233.9%
-19.6%
Q1 25
-606.7%
-25.1%
Q4 24
-243.4%
0.8%
Q3 24
-163.0%
-28.8%
Q2 24
-53.7%
-12.0%
Q1 24
-225.4%
-11.2%
EPS (diluted)
MGX
MGX
SCKT
SCKT
Q4 25
$-0.59
$-1.43
Q3 25
$-0.55
$-0.15
Q2 25
$-0.54
$-0.10
Q1 25
$-0.68
$-0.13
Q4 24
$-0.37
$0.00
Q3 24
$-0.51
$-0.15
Q2 24
$-0.29
$-0.08
Q1 24
$-1.19
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MGX
MGX
SCKT
SCKT
Cash + ST InvestmentsLiquidity on hand
$41.7M
$2.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$158.6M
$4.3M
Total Assets
$221.1M
$14.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MGX
MGX
SCKT
SCKT
Q4 25
$41.7M
$2.0M
Q3 25
$32.8M
$2.0M
Q2 25
$26.9M
$2.6M
Q1 25
$29.2M
$1.7M
Q4 24
$27.4M
$2.5M
Q3 24
$25.1M
$2.9M
Q2 24
$61.2M
$2.1M
Q1 24
$102.6M
$2.8M
Stockholders' Equity
MGX
MGX
SCKT
SCKT
Q4 25
$158.6M
$4.3M
Q3 25
$178.4M
$15.7M
Q2 25
$195.8M
$16.7M
Q1 25
$212.7M
$17.2M
Q4 24
$234.9M
$18.2M
Q3 24
$255.8M
$18.0M
Q2 24
$269.4M
$18.8M
Q1 24
$275.6M
$19.2M
Total Assets
MGX
MGX
SCKT
SCKT
Q4 25
$221.1M
$14.4M
Q3 25
$247.9M
$25.6M
Q2 25
$272.3M
$27.0M
Q1 25
$297.9M
$27.2M
Q4 24
$324.6M
$27.3M
Q3 24
$358.3M
$27.7M
Q2 24
$385.9M
$28.0M
Q1 24
$415.4M
$28.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MGX
MGX
SCKT
SCKT
Operating Cash FlowLast quarter
$-23.5M
$350.4K
Free Cash FlowOCF − Capex
$-23.6M
$189.3K
FCF MarginFCF / Revenue
-604.2%
4.8%
Capex IntensityCapex / Revenue
2.2%
4.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-89.5M
$-1.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MGX
MGX
SCKT
SCKT
Q4 25
$-23.5M
$350.4K
Q3 25
$-21.3M
$-402.8K
Q2 25
$-21.3M
$-464.4K
Q1 25
$-22.8M
$-733.0K
Q4 24
$-26.3M
$-87.0K
Q3 24
$-26.6M
$204.0K
Q2 24
$-26.3M
$-543.5K
Q1 24
$-29.9M
$-94.9K
Free Cash Flow
MGX
MGX
SCKT
SCKT
Q4 25
$-23.6M
$189.3K
Q3 25
$-21.3M
$-589.6K
Q2 25
$-21.4M
$-601.4K
Q1 25
$-23.1M
$-785.3K
Q4 24
$-26.6M
$-310.9K
Q3 24
$-27.8M
$-192.6K
Q2 24
$-27.0M
$-654.9K
Q1 24
$-30.8M
$-151.3K
FCF Margin
MGX
MGX
SCKT
SCKT
Q4 25
-604.2%
4.8%
Q3 25
-246.3%
-19.0%
Q2 25
-251.1%
-14.9%
Q1 25
-560.5%
-19.8%
Q4 24
-276.8%
-6.4%
Q3 24
-241.8%
-5.0%
Q2 24
-134.8%
-12.9%
Q1 24
-275.7%
-3.0%
Capex Intensity
MGX
MGX
SCKT
SCKT
Q4 25
2.2%
4.1%
Q3 25
0.9%
6.0%
Q2 25
1.5%
3.4%
Q1 25
7.0%
1.3%
Q4 24
3.5%
4.6%
Q3 24
10.4%
10.2%
Q2 24
3.3%
2.2%
Q1 24
8.2%
1.1%
Cash Conversion
MGX
MGX
SCKT
SCKT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-2.28×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons